Todd Harris

2017 - Sienna Biopharmaceuticals

In 2017, Todd Harris earned a total compensation of $713.4K as Head of Corporate Development at Sienna Biopharmaceuticals, a 46% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$271,265
Option Awards$102,129
Salary$340,000
Total$713,394

Harris received $340K in salary, accounting for 48% of the total pay in 2017.

Harris also received $271.3K in non-equity incentive plan and $102.1K in option awards.

Rankings

In 2017, Todd Harris' compensation ranked 10,519th out of 14,666 executives tracked by ExecPay. In other words, Harris earned more than 28.3% of executives.

ClassificationRankingPercentile
All
10,519
out of 14,666
28th
Division
Manufacturing
4,088
out of 5,772
29th
Major group
Chemicals And Allied Products
1,452
out of 2,075
30th
Industry group
Drugs
1,183
out of 1,731
32nd
Industry
Pharmaceutical Preparations
921
out of 1,333
31st
Source: SEC filing on April 19, 2018.

Harris' colleagues

We found four more compensation records of executives who worked with Todd Harris at Sienna Biopharmaceuticals in 2017.

2017

Frederick Beddingfield

Sienna Biopharmaceuticals

Chief Executive Officer

2017

Richard Peterson

Sienna Biopharmaceuticals

Chief Financial Officer

2017

Timothy Andrews

Sienna Biopharmaceuticals

General Counsel

2017

John Smither

Sienna Biopharmaceuticals

Chief Financial Officer

News

You may also like